Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS)
Multiple sclerosis (MS) is a prevalent neurologic autoimmune disorder affecting two million people worldwide. Symptoms include gait abnormalities, perception and sensory losses, cranial nerve pathologies, pain, cognitive dysfunction, and emotional aberrancies. Traditional therapy includes corticoste...
Saved in:
Main Authors: | Amnon A. Berger (Author), Emily R. Sottosanti (Author), Ariel Winnick (Author), Jonathan Izygon (Author), Kevin Berardino (Author), Elyse M. Cornett (Author), Alan D. Kaye (Author), Giustino Varrassi (Author), Omar Viswanath (Author), Ivan Urits (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Istradefylline to Treat Patients with Parkinson's Disease Experiencing "Off" Episodes: A Comprehensive Review
by: Amnon A. Berger, et al.
Published: (2020) -
Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects
by: Grace Lassiter, et al.
Published: (2020) -
Very low monomethyl fumarate exposure via human milk: a case report-a contribution from the ConcePTION project
by: Martje Van Neste, et al.
Published: (2024) -
Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
by: Indaco R, et al.
Published: (2008) -
Brachioradial pruritus in a 52-year-old woman: A case report
by: Amnon A. Berger, et al.
Published: (2019)